All In Biotech

Drug Trial Radar · NCT06113471

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Last checked: Nov 20, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

450

Actual

Start

Nov 27, 2023

Primary completion

Mar 17, 2026

Study completion Mar 16, 2027

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Nov 2, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Conditions

  • NonSegmental Vitiligo

Interventions

  • PovorcitinibDrug

    Oral, Tablet

  • PlaceboDrug

    Oral, Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Achieving a ≥ 75% Improvement From Baseline in the Facial Vitiligo Area Scoring Index (F-VASI75)Time frame: Week 52

Locations

86 sites in 9 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham Hospital-Whitaker Clinic

    Birmingham, Alabama

  • C2 Research Center, Llc

    Montgomery, Alabama

  • First Oc Dermatology Research Inc

    Fountain Valley, California

  • Center For Dermatology Clinical Research, Inc

    Fremont, California

  • Marvel Clinical Research Llc

    Huntington Beach, California

  • Vitiligo & Pigmentation Institute of Southern California

    Los Angeles, California

  • Dermatology Research Associates

    Los Angeles, California

  • Clinical Trials Research Institute

    Thousand Oaks, California

  • Skin Care Research, Llc

    Boca Raton, Florida

  • Total Vein and Skin Llc

    Boynton Beach, Florida

  • Driven Research Llc

    Coral Gables, Florida

  • Florida Academic Centers Research and Education Llc

    Coral Gables, Florida

  • Pediatric Skin Research Llc

    Coral Gables, Florida

  • Metabolic Research Institute Inc

    West Palm Beach, Florida

  • Dermatology and Surgery Specialists of North Atlanta

    Marietta, Georgia

  • Advanced Medical Research Pc

    Sandy Springs, Georgia

  • Dundee Dermatology

    West Dundee, Illinois

  • Indiana University School of Medicine Iusm Indianapolis

    Indianapolis, Indiana

  • Delricht Research

    Baton Rouge, Louisiana

  • Callender Dermatology and Cosmetic Center

    Glenn Dale, Maryland

  • Aesthetic and Dermatology Center

    Rockville, Maryland

  • Henry Ford Health System

    Detroit, Michigan

  • Allcutis Research, Llc

    Portsmouth, New Hampshire

  • Weill Cornell Medical College

    New York, New York

  • Remington-Davis Clinical Research

    Columbus, Ohio

  • Oregon Medical Research Center, Pc

    Portland, Oregon

  • Dermatology Treatment and Research Center

    Dallas, Texas

  • Heights Dermatology and Aesthetic Center

    Houston, Texas

  • University of Texas, Md Anderson Cancer

    Houston, Texas

  • Innovative Dermatology: Legacy Medical Village

    Plano, Texas

  • Texas Dermatology and Laser Specialists

    San Antonio, Texas

  • Dermatology Clinical Research Center of San Antonio

    San Antonio, Texas

  • Premier Clinical Research

    Spokane, Washington

  • Medical Center Asklepii Ood

    Dupnitsa, Bulgaria

  • Medical Center Unimed Eood

    Sliven, Bulgaria

  • Ambulatory For Specialized Medical Care - Individual Practice For Specialized Medical Care - Skin An

    Sofia, Bulgaria

  • Aleksandrovska University Hospital

    Sofia, Bulgaria

  • 28 Diagnostic and Consultative Center

    Sofia, Bulgaria

  • British Columbia'S Centre For Dermatologic Science - the Skin Care Centre

    Vancouver, British Columbia, Canada

  • Lynderm Research Inc

    Markham, Ontario, Canada

Showing 40 of 86 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.